May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Differences Between Type 1 and Type 2 Diabetics in the Multifocal Electroretinogram (mfERG)
Author Affiliations & Notes
  • A.J. Adams
    School of Optometry, Univ of California Berkeley, Berkeley, CA
  • J.S. Ng
    School of Optometry, Univ of California Berkeley, Berkeley, CA
  • M.A. Bearse
    School of Optometry, Univ of California Berkeley, Berkeley, CA
  • Y. Han
    School of Optometry, Univ of California Berkeley, Berkeley, CA
  • Footnotes
    Commercial Relationships  A.J. Adams, None; J.S. Ng, None; M.A. Bearse, None; Y. Han, None.
  • Footnotes
    Support  NIH Grant EY02271 & T32 EY07043
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 344. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.J. Adams, J.S. Ng, M.A. Bearse, Y. Han; Differences Between Type 1 and Type 2 Diabetics in the Multifocal Electroretinogram (mfERG) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):344.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine whether differences in mfERG measures exist between type 1 and type 2 diabetic patients of similar diabetes duration. Methods: We conducted a retrospective analysis of one eye of each of 8 type 1 and 8 type 2 diabetic subjects. The groups were matched in duration of diabetes (mean type 1: 13.1 ± 10.5 yrs; type 2: 10.6 ± 6.4 yrs) and retinopathy level, but differed in age (type 1: 37.2 ± 11.3 yrs; type 2: 55.2 ± 7.8 yrs). Three subjects in each group had mild to moderate non–proliferative diabetic retinopathy, mostly microaneurysms outside of the central 7 deg, and 5 subjects in each group had no signs of retinopathy. 30 age–similar controls (44.5 ± 11.5 yrs) were also examined. MfERGs were recorded using VERIS 4 (103 elements covering the central 45 deg, dilated pupils, and 10–100 Hz filtering). First–order mfERG implicit time (IT) and amplitude (AMP) were derived using a template stretching method (Hood & Li, 1997). For each subject, IT and AMP measures were averaged across the 103 retinal locations. Analysis using 5 concentric rings was also performed. The groups were compared using two–tailed t–tests. Blood glucose level at the time of mfERG testing and HbA1c level were also examined. Results: Mean ITs (type 1: 28.9 ± 0.78 ms; type 2: 30.7 ± 0.88 ms; controls: 28.7 ± 0.72 ms) differed between the diabetic groups (p<0.01), as well as between type 2 diabetics and controls (p<0.01). The ring analysis showed that the ITs of the diabetic groups differed in all rings outside of the central 7 deg (p<0.001). The ITs of type 2 subjects also differed from the control group outside of the central 7 deg (p<0.001). A small, statistically significant difference was seen for mean ITs as a function of age within the control group (R2=0.27, p<0.01). The mean ITs of the diabetic groups remained significantly different after adjusting for the effect of age (p<0.001). No significant differences in AMP were found among the type 1, type 2, and control groups. Blood glucose (p=0.51) and HbA1c (p=0.80) levels did not differ between the diabetic groups. Conclusions: Implicit times of type 2 diabetics are abnormally delayed compared to type 1 diabetics and controls even after attempting to match diabetic duration and retinopathy level, and adjusting for age. Delays in diagnosis of type 2 diabetes may have contributed to their increased implicit times, as both the total duration and the duration of uncontrolled/untreated diabetes may have been underestimated.

Keywords: diabetes • diabetic retinopathy • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×